- Home
- NAVI vs ELVN Comparison
NAVI vs ELVN Comparison
Compare NAVI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAVI
- ELVN
- Stock Information
- Founded
- NAVI 1973
- ELVN 2016
- Country
- NAVI United States
- ELVN United States
- Employees
- NAVI N/A
- ELVN N/A
- Industry
- NAVI Investment Bankers/Brokers/Service
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- NAVI Finance
- ELVN Health Care
- Exchange
- NAVI Nasdaq
- ELVN Nasdaq
- Market Cap
- NAVI 1.3B
- ELVN 1.2B
- IPO Year
- NAVI N/A
- ELVN 2020
- Fundamental
- Price
- NAVI $12.94
- ELVN $21.55
- Analyst Decision
- NAVI Hold
- ELVN Strong Buy
- Analyst Count
- NAVI 7
- ELVN 5
- Target Price
- NAVI $14.36
- ELVN $41.20
- AVG Volume (30 Days)
- NAVI 667.5K
- ELVN 411.0K
- Earning Date
- NAVI 10-29-2025
- ELVN 11-12-2025
- Dividend Yield
- NAVI 4.95%
- ELVN N/A
- EPS Growth
- NAVI N/A
- ELVN N/A
- EPS
- NAVI 0.31
- ELVN N/A
- Revenue
- NAVI $584,000,000.00
- ELVN N/A
- Revenue This Year
- NAVI N/A
- ELVN N/A
- Revenue Next Year
- NAVI N/A
- ELVN $20.05
- P/E Ratio
- NAVI $41.89
- ELVN N/A
- Revenue Growth
- NAVI N/A
- ELVN N/A
- 52 Week Low
- NAVI $10.53
- ELVN $13.30
- 52 Week High
- NAVI $16.15
- ELVN $29.79
- Technical
- Relative Strength Index (RSI)
- NAVI 55.28
- ELVN 56.37
- Support Level
- NAVI $12.08
- ELVN $20.10
- Resistance Level
- NAVI $13.09
- ELVN $21.88
- Average True Range (ATR)
- NAVI 0.28
- ELVN 1.00
- MACD
- NAVI 0.09
- ELVN 0.01
- Stochastic Oscillator
- NAVI 87.07
- ELVN 64.44
About NAVI Navient Corporation
Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in three segments: Federal Education Loans, Consumer Lending, and Business Processing. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.